Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (101-110 of 345) with videos related to

Pageof 35
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
JAMA Network Open|March 10, 2021
Association of Socioeconomic Status With Risk Factor Target Achievements and Use of Secondary Prevention After Myocardial InfarctionJoel Ohm, Per H Skoglund, Henrike Häbel, et al.
European Journal of Preventive Cardiology|April 18, 2018
Socioeconomic status predicts second cardiovascular event in 29,226 survivors of a first myocardial infarctionJoel Ohm, Per H Skoglund, Andrea Discacciati, et al.
American Heart Journal|June 24, 2010
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)Karolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
The American Journal of Medicine|May 8, 2023
First Sampled High-Sensitive Cardiac Troponin T is Associated With One-Year Mortality in Sepsis Patients and 30- to 365-Day Mortality in Sepsis SurvivorsSamantha Lörstad, Shajan Shekarestan, Tomas Jernberg, et al.
Plos One|April 26, 2019
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)Anna M Nordenskjöld, Kai M Eggers, Tomas Jernberg, et al.
BMJ Open|May 12, 2023
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort studyMargret Leosdottir, Emil Hagstrom, Nermin Hadziosmanovic, et al.
International Journal for Equity in Health|November 4, 2025
Socio-geographical disparities in cardiometabolic multimorbidity in Sweden: an Intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (I-MAIHDA)Kanya Anindya, Juan Merlo, Lars Lind, et al.
American Heart Journal|May 3, 2025
Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracyMargret Leosdottir, Lars Dahlbom, Maria Bäck, et al.
European Journal of Preventive Cardiology|February 15, 2017
Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal functionMasih Khedri, Karolina Szummer, Juan-Jesus Carrero, et al.
Pageof 35

Showing results (101-110 of 345) with videos related to

Sort By:
Pageof 35
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.
JAMA Network Open|March 10, 2021
Association of Socioeconomic Status With Risk Factor Target Achievements and Use of Secondary Prevention After Myocardial InfarctionJoel Ohm, Per H Skoglund, Henrike Häbel, et al.
European Journal of Preventive Cardiology|April 18, 2018
Socioeconomic status predicts second cardiovascular event in 29,226 survivors of a first myocardial infarctionJoel Ohm, Per H Skoglund, Andrea Discacciati, et al.
American Heart Journal|June 24, 2010
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)Karolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
The American Journal of Medicine|May 8, 2023
First Sampled High-Sensitive Cardiac Troponin T is Associated With One-Year Mortality in Sepsis Patients and 30- to 365-Day Mortality in Sepsis SurvivorsSamantha Lörstad, Shajan Shekarestan, Tomas Jernberg, et al.
Plos One|April 26, 2019
Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)Anna M Nordenskjöld, Kai M Eggers, Tomas Jernberg, et al.
BMJ Open|May 12, 2023
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort studyMargret Leosdottir, Emil Hagstrom, Nermin Hadziosmanovic, et al.
International Journal for Equity in Health|November 4, 2025
Socio-geographical disparities in cardiometabolic multimorbidity in Sweden: an Intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (I-MAIHDA)Kanya Anindya, Juan Merlo, Lars Lind, et al.
American Heart Journal|May 3, 2025
Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracyMargret Leosdottir, Lars Dahlbom, Maria Bäck, et al.
European Journal of Preventive Cardiology|February 15, 2017
Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal functionMasih Khedri, Karolina Szummer, Juan-Jesus Carrero, et al.
Pageof 35